Reference
Health Canada. Summary Safety Review - Dopamine agonists (apomorphine-, bromocriptine-, cabergoline-, pergolide-, pramipexole-, quinagolide-, ropinirole-, rotigotine-containing products) - Health Canada. Internet Document : 8 Jun 2021. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00269
Rights and permissions
About this article
Cite this article
Summary Safety Review: dopamine agonist withdrawal syndrome. Reactions Weekly 1861, 5 (2021). https://doi.org/10.1007/s40278-021-97805-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-97805-1